Skip to main
SYRE

SYRE Earnings Dates & Reports

SYRE Most Recent Earnings

Report Date
Period EndingQ1 2026
Est. EPS-$0.66
Actual EPS-$0.74
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

SYRE Earnings per Share (EPS) History

Signup for full access
Browse free

SYRE Latest Earnings

The value each SYRE share was expected to gain vs. the value each share gained.

SYRE reported its most recent earnings on for Q1 2026, posting earnings per share (EPS) of -$0.74. This exceeded analysts' expectations of -$0.66 by 12.12%, marking a Miss.

For comparison, Spyre Therapeutics Inc reported EPS of $0 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.70.

SYRE Earnings History

Earnings
Est. EPSActual EPSSurprise
Q2 2026
-$0.70
Q1 2026
-$0.66-$0.74+12.12%
Q4 2025
-$0.74-$0.70-5.41%
Q3 2025
-$0.72-$0.15-79.17%
Q2 2025
-$0.72-$0.49-31.94%

SYRE Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Spyre Therapeutics Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

SYRE Earnings FAQs

SYRE last reported earnings on May 5, 2026 for Q1 2026, posting an EPS of -$0.74, which Miss the estimate of -$0.66 by 12.12%.

For Q1 2026, SYRE reported an EPS of -$0.74, missing analysts' estimate of -$0.66 by 12.12%.

For Q1 2026, SYRE Miss expectations with an actual EPS of -$0.74 vs. an estimated EPS of -$0.66.

Following the last earnings report on May 5, 2026, SYRE's stock price moved — from — to —.

The next SYRE earnings call is scheduled for Aug. 4, 2026, where executives will discuss financial results and outlook.

Spyre Therapeutics Inc (SYRE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.